Fig. 5

Dynamic profile of laboratory markers in patients with severe COVID-19 and HBV co-infection from illness onset (non-corticosteroid treatment vs corticosteroid treatment). This figure shows dynamic profile in ALT (A), Bilirubin (B), Neutrophil count (C), Lymphocyte count (D), IL-6 (E), and d-dimer (F) from the onset of the disease to 28 days. The bars represent interquartile range. ^aP < 0.05 indicate differences between non-corticosteroid treatment vs corticosteroid treatment. COVID-19: coronavirus disease 2019; HBV: hepatitis B virus; ALT: alanine amino transferase; IL-6: interleukin-6